Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Abel, S.
Right arrow Articles by Gelderblom, W.C.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abel, S.
Right arrow Articles by Gelderblom, W.C.A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 5, 795-804, May 2001
© 2001 Oxford University Press


CARCINOGENESIS

Changes in essential fatty acid patterns associated with normal liver regeneration and the progression of hepatocyte nodules in rat hepatocarcinogenesis

S. Abel3,, C.M. Smuts1,, C. de Villiers2, and W.C.A. Gelderblom

Programme on Mycotoxins and Experimental Carcinogenesis,
1 National Research Programme for Nutritional Intervention,
2 Experimental Biology Programme–Primate Unit, Medical Research Council (MRC) ,PO Box 19070, Tygerberg 7505, South Africa

Changes in lipid metabolism were monitored in rat hepatocyte nodules at certain time points over 9 months. Tissue obtained from partially hepatectomized rats, collected over a period of 7 days, were included as a control for normal hepatocyte cell proliferation. Two important features regarding the lipid profiles of hepatocyte nodules and normal regenerating liver were the increased concentrations of phosphatidylethanolamine (PE), resulting in a decreased phosphatidylcholine/phosphatidylethanolamine (PC/PE) ratio, and cholesterol. These changes coincided with increased membrane fluidity in the nodules and regenerating liver. With respect to the fatty acid (FA) profiles of the nodules, C18:1{omega}9 and C18:2{omega}6 increased in PE and PC whereas C20:4{omega}6 decreased in PC and increased in PE. C22:5{omega}6 and C22:6{omega}3, the end products of the {omega}6 and {omega}3 metabolic pathways, respectively, decreased in PC and remained unchanged in PE. The FA levels in PC reflected an impaired {delta}-6 desaturase enzyme, whereas this effect was masked in PE due to the increased concentration of this phospholipid fraction. In regenerating liver, the FA profiles of PC and PE showed the same pattern as described for the hepatocyte nodules, except for C18:1{omega}9 which decreased in PC and increased non-significantly in PE. The increased C18:1{omega}9 level, a FA with anti-oxidative properties, as well as the decreased levels of the long-chain polyunsaturated fatty acids (C20 and C22 carbon chains), have been associated with the decreased lipid peroxidation level in hepatocyte nodules. The resultant decrease in peroxidative metabolites, known to affect apoptosis, could be important in the progression of the nodules into neoplasia. The present results indicate that the altered lipid parameters associated with hepatocyte nodules closely mimics cellular proliferation in regenerating liver and could be responsible for the enhanced proliferation and/or altered growth pattern in these lesions. The altered FA profiles suggest various pathways in which FA could play a role in transmembrane signalling related to the altered cell proliferative and apoptotic pathways. The persistent changes in the hepatocyte nodules suggest that the lipid metabolism escapes the regulatory mechanisms required for normal cellular homeostasis at different levels.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
J. Griffitts, Y. Tesiram, G. E. Reid, D. Saunders, R. A. Floyd, and R. A. Towner
In vivo MRS assessment of altered fatty acyl unsaturation in liver tumor formation of a TGF{alpha}/c-myc transgenic mouse model
J. Lipid Res., April 1, 2009; 50(4): 611 - 622.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. de Moura Espindola, R. P. Mazzantini, T. P. Ong, A. de Conti, R. Heidor, and F. S. Moreno
Geranylgeraniol and {beta}-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-{kappa}B activation
Carcinogenesis, June 1, 2005; 26(6): 1091 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. Rossi, E. Graner, P. Febbo, L. Weinstein, N. Bhattacharya, T. Onody, G. Bubley, S. Balk, and M. Loda
Fatty Acid Synthase Expression Defines Distinct Molecular Signatures in Prostate Cancer
Mol. Cancer Res., August 1, 2003; 1(10): 707 - 715.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.